Position in AUPH
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$212,464
+$13,580 QoQ
Shares Held
12,520
-6.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#184
of 279 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $50,552,262 across 50 Biotechnology names. AUPH ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,129 | $13,798,316 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
146,259 | $5,705,563 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
15,400 | $2,884,112 | |
| 4 | TYRA |
Tyra Biosciences, Inc.
|
83,783 | $2,676,029 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,250 | $2,111,102 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
99,771 | $1,860,729 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
75,714 | $1,823,193 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
107,453 | $1,818,104 |
All Filings in AUPH
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,464 | 12,520 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $198,884 | 13,420 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $214,049 | 13,420 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $148,291 | 13,420 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $113,667 | 13,420 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $107,816 | 13,410 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $129,401 | 14,410 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $107,824 | 14,710 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $83,994 | 14,710 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $76,202 | 15,210 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $170,000 | 18,910 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $146,853 | 18,900 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $182,952 | 18,900 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $234,544 | 21,400 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $79,488 | 18,400 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $162,432 | 21,600 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $237,180 | 23,600 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $279,788 | 22,600 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $457,400 | 20,000 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $393,914 | 17,800 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $396,109 | 30,564 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $393,315 | 30,290 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||